Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec;45(6):2294-2308.
doi: 10.1007/s10753-022-01691-4. Epub 2022 Jul 5.

Gallic Acid Improves Therapeutic Effects of Mesenchymal Stem Cells Derived from Adipose Tissue in Acute Renal Injury Following Rhabdomyolysis Induced by Glycerol

Affiliations

Gallic Acid Improves Therapeutic Effects of Mesenchymal Stem Cells Derived from Adipose Tissue in Acute Renal Injury Following Rhabdomyolysis Induced by Glycerol

Seyyed Ali Mard et al. Inflammation. 2022 Dec.

Abstract

Acute kidney injury (AKI) is identified by a progressive reduction in the glomerular filtration rate (GFR) and retention of nitrogenous waste products. Traumatic and nontraumatic rhabdomyolysis is recently considered the main cause of AKI. According to several studies, stem cell treatment is a promising therapeutic strategy for many types of disorders including AKI. The main limitation of mesenchymal stem cells (MSCs) therapy is reducing cell survival in response to oxidative stress products in injured organ areas. Gallic acid (GA) as a well-known antioxidant has been reported to confer potent-free radical scavenging and anti-inflammatory properties. Therefore, the aim of the current study was to assess the influence of MSCs and GA in acute renal injury following rhabdomyolysis induced by glycerol. A total of 70 healthy rats were divided into seven groups (10 in each group): control, AKI (glycerol, intramuscular), cell therapy (AKI + intravenous injection of mesenchymal stem cells derived from adipose tissue (AMCs), AKI + AMCs + GA (50, 100, and 200 mg/kg, intraperitoneally, 3 days a week for 3 consecutive weeks), and positive control group (the most effective dose of gallic acid). After the treatment, rats were sacrificed; blood, urine, and kidney tissues were collected; and qualitative and quantitative parameters (including blood urea nitrogen (BUN), creatine kinase (CK), lactate dehydrogenase (LDH), alkaline phosphatase (ALP), aspartate transaminase (SGOT), oxidative stress markers kidney function parameters) and histopathological indexes were assayed. Our results revealed that co-treatment of AMCs plus GA into AKI rats decreased BUN and creatinine and ameliorated kidney injury parameters after 3 weeks. Improved oxidative stress markers such as decreased MDA and increased SOD and CAT were significant in the GA + AMCs group compared to the AMCs alone in AKI rats. Also, the histopathological appearances of AKI rats including renal tubule cavity expansion and renal tubular epithelial cell edema, and interstitial inflammation, were alleviated using GA + AMCs treatment compared to the control. The obtained results of the current study documented that antioxidants could make mesenchymal stem cells more resistant to the condition in which they are supposed to be transplanted and probably improve the efficacy of stem cell therapy in AKI patients.

Keywords: Acute renal injury; Adipose tissue; Gallic acid; Mesenchymal stem cells; Rhabdomyolysis.

PubMed Disclaimer

References

    1. Makris, K., and L. Spanou. 2016. Acute kidney injury: Definition, pathophysiology and clinical phenotypes. The clinical biochemist reviews. 37 (2): 85. - PubMed - PMC
    1. Kellum, J.A., and N. Lameire. 2013. Diagnosis, evaluation, and management of acute kidney injury: A KDIGO summary (part 1). Critical care. 17 (1): 1–5. - DOI
    1. Nishimura, H., H. Enokida, S. Kawahira, I. Kagara, H. Hayami, and M. Nakagawa. 2016. Acute kidney injury and rhabdomyolysis after Protobothrops flavoviridis bite: A retrospective survey of 86 patients in a tertiary care center. The American journal of tropical medicine and hygiene. 94 (2): 474–479. - DOI - PubMed - PMC
    1. Keltz, E., F.Y. Khan, and G. Mann. 2013. Rhabdomyolysis. The role of diagnostic and prognostic factors. Muscles, ligaments and tendons journal. 3 (4): 303.
    1. Emzhik, M., P. Makhdoumi, N. Milani, and B. Dadpour. 2019. Role of acetaminophen in reducing risk of kidney injury from rhabdomyolysis: A narrative review. Asia Pacific Journal of Medical Toxicology. 8 (2): 61–64.

LinkOut - more resources